Steele, Joel Ricky, et al. “A Novel Method for Creating a Synthetic L-DOPA Proteome and In Vitro Evidence of Incorporation.” Proteomes, no. 2, MDPI AG, May 2021, p. 24. Crossref, doi:10.3390/proteomes9020024.

Abstract

Proteinopathies are protein misfolding diseases that have an underlying factor that affects the conformation of proteoforms. A factor hypothesised to play a role in these diseases is the incorporation of non-protein amino acids into proteins, with a key example being the therapeutic drug levodopa. The presence of levodopa as a protein constituent has been explored in several studies, but it has not been examined in a global proteomic manner. This paper provides a proof-of-concept method for enzymatically creating levodopa-containing proteins using the enzyme tyrosinase and provides spectral evidence of in vitro incorporation in addition to the induction of the unfolded protein response due to levodopa.